Dimethyl sulfoxide induces both direct and indirect Tau hyperphosphorylation

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Julien, Carl ^a,b   Marcouiller, François ^a,b   Bretteville, Alexis ^a,b   El Khoury, Noura B ^a,b   Baillargeon, Joanie ^a,b   Hébert, Sébastien S ^a,b   Planel, Emmanuel ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CYCLIN DEPENDENT KINASE 5; DIMETHYL SULFOXIDE; EPITOPE; GLYCOGEN SYNTHASE KINASE 3BETA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN AT180; PROTEIN AT8; PROTEIN P35; PROTEIN PHF 1; SERINE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TAU PROTEIN; THREONINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFECT; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN CELL; HYPOTHERMIA; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PROTEIN DOMAIN; PROTEIN HYPERPHOSPHORYLATION; PROTEIN PHOSPHORYLATION;

ANIMALS; BODY TEMPERATURE; CELL LINE, TUMOR; DIMETHYL SULFOXIDE; GLYCOGEN SYNTHASE KINASE 3; HIPPOCAMPUS; HUMANS; HYPOTHERMIA, INDUCED; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAPERITONEAL; MICE; MICE, INBRED C57BL; PHOSPHOPROTEIN PHOSPHATASES; PHOSPHORYLATION; TAU PROTEINS; TIME FACTORS; TRANSFECTION;

ANIMALIA; MUS;

EID: 84863109223     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040020     Document Type: Article

References (50)

1. Balakin KV, Savchuk NP, Tetko IV, (2006) In silico approaches to prediction of aqueous and DMSO solubility of drug-like compounds: trends, problems and solutions. Curr Med Chem 13: 223-241.
2. Santos NC, Figueira-Coelho J, Martins-Silva J, Saldanha C, (2003) Multidisciplinary utilization of dimethyl sulfoxide: pharmacological, cellular, and molecular aspects. Biochem Pharmacol 65: 1035-1041.
3. Watanabe E, Sudo R, Takahashi M, Hayashi M, (2000) Evaluation of absorbability of poorly water-soluble drugs: validity of the use of additives. Biol Pharm Bull 23: 838-843.
4. Wood DC, Wood J, (1975) Pharmacologic and biochemical considerations of dimethyl sulfoxide. Ann N Y Acad Sci 243: 7-19.
5. Lovelock JE, Bishop MW, (1959) Prevention of freezing damage to living cells by dimethyl sulphoxide. Nature 183: 1394-1395.
6. Pegg DE, (2007) Principles of cryopreservation. Methods Mol Biol 368: 39-57.
7. Martins DF, Rosa AO, Gadotti VM, Mazzardo-Martins L, Nascimento FP, et al. (2011) The antinociceptive effects of AR-A014418, a selective inhibitor of glycogen synthase kinase-3 beta, in mice. J Pain 12: 315-322.
8. Selenica M-L, Jensen HS, Larsen AK, Pedersen ML, Helboe L, et al. (2007) Efficacy of small-molecule glycogen synthase kinase-3 inhibitors in the postnatal rat model of tau hyperphosphorylation. Br J Pharmacol 152: 959-979.
9. de Oliveira ACP, Candelario-Jalil E, Langbein J, Wendeburg L, Bhatia HS, et al. (2012) Pharmacological inhibition of Akt and downstream pathways modulates the expression of COX-2 and mPGES-1 in activated microglia. J Neuroinflammation 9: 2.
10. Ring DB, Johnson KW, Henriksen EJ, Nuss JM, Goff D, et al. (2003) Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo. Diabetes 52: 588-595.
11. Jacob SW, la Torre de JC, (2009) Pharmacology of dimethyl sulfoxide in cardiac and CNS damage. Pharmacol Rep 61: 225-235.
12. Regelson W, Harkins SW, (1997) "Amyloid is not a tombstone-"a summation. The primary role for cerebrovascular and CSF dynamics as factors in Alzheimer's disease (AD): DMSO, fluorocarbon oxygen carriers, thyroid hormonal, and other suggested therapeutic measures. Ann N Y Acad Sci 826: 348-374.
13. Caujolle F, Caujolle D, H B, Calvet MM, (1964) [Toxicity and pharmacological aptitudes of dimethylsulfoxide]. C R Hebd Seances Acad Sci 258: 2224-2226.
14. Farrant J, (1964) Pharmacological actions and toxicity of dimethyl sulphoxide and other compounds which protect smooth muscle during freezing and thawing. J Pharm Pharmacol 16: 472-483.
15. Goedert M, (1996) Tau protein and the neurofibrillary pathology of Alzheimer's disease. Ann N Y Acad Sci 777: 121-131.
16. Goedert M, Jakes R, Vanmechelen E, (1995) Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205. Neurosci Lett 189: 167-169.
17. Goedert M, Jakes R, Crowther RA, Cohen P, Vanmechelen E, et al. (1994) Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein. Biochem J 301(Pt 3): 871-877.
18. Biernat J, Mandelkow EM, Schröter C, Lichtenberg-Kraag B, Steiner B, et al. (1992) The switch of tau protein to an Alzheimer-like state includes the phosphorylation of two serine-proline motifs upstream of the microtubule binding region. EMBO J 11: 1593-1597.
19. Porzig R, Singer D, Hoffmann R, (2007) Epitope mapping of mAbs AT8 and Tau5 directed against hyperphosphorylated regions of the human tau protein. Biochem Biophys Res Commun 358: 644-649.
20. Whittington RA, Virag L, Marcouiller F, Papon M-A, El Khoury NB, et al. (2011) Propofol directly increases tau phosphorylation. PLoS ONE 6: e16648.
21. Planel E, Tatebayashi Y, Miyasaka T, Liu L, Wang L, et al. (2007) Insulin dysfunction induces in vivo tau hyperphosphorylation through distinct mechanisms. J Neurosci 27: 13635-13648.
22. Su JH, Cummings BJ, Cotman CW, (1994) Early phosphorylation of tau in Alzheimer's disease occurs at Ser-202 and is preferentially located within neurites. Neuroreport 5: 2358-2362.
23. Goedert M, Cohen ES, Jakes R, Cohen P, (1992) p42 MAP kinase phosphorylation sites in microtubule-associated protein tau are dephosphorylated by protein phosphatase 2A1. Implications for Alzheimer's disease [corrected]. FEBS Lett 312: 95-99.
24. Wang J-Z, Grundke-Iqbal I, Iqbal K, (1996) Restoration of biological activity of Alzheimer abnormally phosphorylated tau by dephosphorylation with protein phosphatase-2A,-2B and-1. Brain Res Mol Brain Res 38: 200-208.
25. Planel E, Bretteville A, Liu L, Virag L, Du AL, et al. (2009) Acceleration and persistence of neurofibrillary pathology in a mouse model of tauopathy following anesthesia. FASEB J 23: 2595-2604.
26. Planel E, Richter KEG, Nolan CE, Finley JE, Liu L, et al. (2007) Anesthesia leads to tau hyperphosphorylation through inhibition of phosphatase activity by hypothermia. J Neurosci 27: 3090-3097.
27. Planel E, Miyasaka T, Launey T, Chui D-H, Tanemura K, et al. (2004) Alterations in glucose metabolism induce hypothermia leading to tau hyperphosphorylation through differential inhibition of kinase and phosphatase activities: implications for Alzheimer's disease. J Neurosci 24: 2401-2411.
28. Whittington RA, Papon M-A, Chouinard F, Planel E, (2010) Hypothermia and Alzheimer's disease neuropathogenic pathways. Curr Alzheimer Res 7: 717-725.
29. Feng Q, Cheng B, Yang R, Sun F-Y, Zhu C-Q, (2005) Dynamic changes of phosphorylated tau in mouse hippocampus after cold water stress. Neurosci Lett 388: 13-16.
30. Korneyev A, Binder L, Bernardis J, (1995) Rapid reversible phosphorylation of rat brain tau proteins in response to cold water stress. Neurosci Lett 191: 19-22.
31. Okawa Y, Ishiguro K, Fujita SC, (2003) Stress-induced hyperphosphorylation of tau in the mouse brain. FEBS Lett 535: 183-189.
32. Ashwood-Smith MJ, (1967) Radioprotective and cryoprotective properties of dimethyl sulfoxide in cellular systems. Ann N Y Acad Sci 141: 45-62.
33. Patel SJ, Milwid JM, King KR, Bohr S, Iracheta-Velle A, et al. (2012) Gap junction inhibition prevents drug-induced liver toxicity and fulminant hepatic failure. Nat Biotechnol 30: 179-183.
34. Dugo L, Collin M, Allen DA, Patel NSA, Bauer I, et al. (2005) GSK-3beta inhibitors attenuate the organ injury/dysfunction caused by endotoxemia in the rat. Crit Care Med 33: 1903-1912.
35. Roller J, Laschke MW, Scheuer C, Menger MD, (2010) Heme oxygenase (HO)-1 protects from lipopolysaccharide (LPS)-mediated liver injury by inhibition of hepatic leukocyte accumulation and improvement of microvascular perfusion. Langenbecks Arch Surg 395: 387-394.
36. Villarreal JS, Barea-Rodriguez EJ, (2006) ERK phosphorylation is required for retention of trace fear memory. Neurobiol Learn Mem 85: 44-57.
37. Pohjanvirta R, Korkalainen M, McGuire J, Simanainen U, Juvonen R, et al. (2002) Comparison of acute toxicities of indolo[3,2-b]carbazole (ICZ) and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in TCDD-sensitive rats. Food Chem Toxicol 40: 1023-1032.
38. Zhu GC, Ding Z, Chen ZS, Dong C, Guo H, et al. (2006) Experimental study on genistein prevention and treatment of transplant arteriosclerosis in aortic transplants of rat. Transplant Proc 38: 3307-3308.
39. Mailliot C, Bussière T, Hamdane M, Sergeant N, Caillet ML, et al. (2000) Pathological tau phenotypes. The weight of mutations, polymorphisms, and differential neuronal vulnerabilities. Ann N Y Acad Sci 920: 107-114.
40. Altland PD, Highman B, Parker M, (1966) Induction of hypothermia by dimethyl sulfoxide in rats exposed to cold: tissue and enzyme changes. Proc Soc Exp Biol Med 123: 853-859.
41. Planel E, Yasutake K, Fujita SC, Ishiguro K, (2001) Inhibition of protein phosphatase 2A overrides tau protein kinase I/glycogen synthase kinase 3 beta and cyclin-dependent kinase 5 inhibition and results in tau hyperphosphorylation in the hippocampus of starved mouse. J Biol Chem 276: 34298-34306.
42. Qian W, Shi J, Yin X, Iqbal K, Grundke-Iqbal I, et al. (2010) PP2A regulates tau phosphorylation directly and also indirectly via activating GSK-3beta. J Alzheimers Dis 19: 1221-1229.
43. Goldbaum O, Richter-Landsberg C, (2002) Activation of PP2A-like phosphatase and modulation of tau phosphorylation accompany stress-induced apoptosis in cultured oligodendrocytes. Glia 40: 271-282.
44. Green KN, Steffan JS, Martinez-Coria H, Sun X, Schreiber SS, et al. (2008) Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau. J Neurosci 28: 11500-11510.
45. Paquet D, Bhat R, Sydow A, Mandelkow E-M, Berg S, et al. (2009) A zebrafish model of tauopathy allows in vivo imaging of neuronal cell death and drug evaluation. J Clin Invest 119: 1382-1395.
46. Broadwell R, Salcman M, Kaplan R, (1982) Morphologic effect of dimethyl sulfoxide on the blood-brain barrier. Science 217: 164-166.
47. Delobel P, Flament S, Hamdane M, Mailliot C, Sambo A-V, et al. (2002) Abnormal Tau phosphorylation of the Alzheimer-type also occurs during mitosis. J Neurochem 83: 412-420.
48. Hamdane M, Sambo A-V, Delobel P, Bégard S, Violleau A, et al. (2003) Mitotic-like tau phosphorylation by p25-Cdk5 kinase complex. J Biol Chem 278: 34026-34034.
49. Hamdane M, Bretteville A, Sambo A-V, Schindowski K, Bégard S, et al. (2005) p25/Cdk5-mediated retinoblastoma phosphorylation is an early event in neuronal cell death. J Cell Sci 118: 1291-1298.
50. Otvos L, Feiner L, Lang E, Szendrei GI, Goedert M, et al. (1994) Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404. J Neurosci Res 39: 669-673.